Skip to main content

Antispasmodics

  • Chapter
  • First Online:
  • 2325 Accesses

Abstract

Antispasmodics and antispasticity agents are used to treat low back pain and muscle spasms and to break the “pain-spasm-pain” cycle. Although the mechanisms of action are not fully understood, it is generally thought that antispasmodics depress polysynaptic reflexes within the dorsal horn of the spinal cord at spinal interneurons, and antispasticity agents reduce skeletal muscle hypertonicity and contractions at the level of the spinal cord and skeletal muscle. There is no clear evidence that one drug is superior than others for treatment of spasm. Use caution when prescribing these agents to patients who concomitantly use other sedatives.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Suggested Reading

  1. Baclofen Tablet package insert. Sellersville: Teva Pharmaceuticals USA; 2010 Jun.

    Google Scholar 

  2. Chlorzoxazone package insert. Sayreville: Vertical Pharmaceutical; 2010 Oct.

    Google Scholar 

  3. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–91.

    Article  PubMed  Google Scholar 

  4. Jackson K, Argoff C, Dubin A. Skeletal muscle relaxants. In: Practical management of pain. 5th ed. Philadelphia: Elsevier; 2014. p. 569–73.

    Chapter  Google Scholar 

  5. Metaxalone package insert. Bristol: King Pharmaceuticals, Inc.; 2008 Apr.

    Google Scholar 

  6. Methocarbamol package insert. Philadelphia: Lennett Co., Inc.; 2007 Jan.

    Google Scholar 

  7. Orphenadrine citrate package insert. Schaumburg: Sagent Pharmaceuticals; 2009 Dec.

    Google Scholar 

  8. Soma (carisoprodol) package insert Charlotte. North Carolina: Vintage Pharmaceuticals, Inc.; 2006 June.

    Google Scholar 

  9. Valium (diazepam) package insert Nutley. New Jersey: Roche Laboratories Inc.; 2008 Jan.

    Google Scholar 

  10. Witenko C, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. Pharmacy & Therapeutics. 2014;39(6):427–35.

    Google Scholar 

  11. Zanaflex tablets (tizanidine hydrochloride) package insert. Hawthorne: Acorda Therapeutics Inc.; 2006 July.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew M. Hall MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Hall, A.M. (2017). Antispasmodics. In: Pope, J., Deer, T. (eds) Treatment of Chronic Pain Conditions. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6976-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6976-0_24

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6974-6

  • Online ISBN: 978-1-4939-6976-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics